Abvc Biopharma ABVC
NASDAQ ABVC
$0.90 -0.08 (-8.16%)
At close: Nov 13, 2026 · 4:00 PM EST

Abvc Biopharma (ABVC) Construction in Progress (2023 - 2025)

Updated

Abvc Biopharma (ABVC) reported Construction in Progress of $8.09 million for Q3 2025, up 9.4% from $7.4 million a year earlier and unchanged from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Construction in Progress (2023 - 2025) Analysis & Trends

Dating back to Q3 2023, Abvc Biopharma's Construction in Progress record includes 9 quarters.

  • By year, Construction in Progress came in at $569,278 in FY2023.
  • Per Business Quant data, the three quarters before Q3 2025 came in at $8.09 million (Q2 2025), $8.09 million (Q1 2025) and $8.09 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Abvc Biopharma 24.28 Mn 21.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 8.09 Mn
Jun 30, 2025 8.09 Mn
Mar 31, 2025 8.09 Mn
Dec 31, 2024 8.09 Mn
Sep 30, 2024 7.40 Mn
Jun 30, 2024 529,121.00
Mar 31, 2024 549,150.00
Dec 31, 2023 569,278.00
Sep 30, 2023 7.40 Mn
API Access

Abvc Biopharma Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=ABVC&period=max&api_key=YOUR_API_KEY